Dax1 modulates ERα-dependent hypothalamic estrogen sensing in female mice.


Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
29 05 2023
Historique:
received: 23 05 2022
accepted: 10 05 2023
medline: 31 5 2023
pubmed: 30 5 2023
entrez: 29 5 2023
Statut: epublish

Résumé

Coupling the release of pituitary hormones to the developmental stage of the oocyte is essential for female fertility. It requires estrogen to restrain kisspeptin (KISS1)-neuron pulsatility in the arcuate hypothalamic nucleus, while also exerting a surge-like effect on KISS1-neuron activity in the AVPV hypothalamic nucleus. However, a mechanistic basis for this region-specific effect has remained elusive. Our genomic analysis in female mice demonstrate that some processes, such as restraint of KISS1-neuron activity in the arcuate nucleus, may be explained by region-specific estrogen receptor alpha (ERα) DNA binding at gene regulatory regions. Furthermore, we find that the Kiss1-locus is uniquely regulated in these hypothalamic nuclei, and that the nuclear receptor co-repressor NR0B1 (DAX1) restrains its transcription specifically in the arcuate nucleus. These studies provide mechanistic insight into how ERα may control the KISS1-neuron, and Kiss1 gene expression, to couple gonadotropin release to the developmental stage of the oocyte.

Identifiants

pubmed: 37248237
doi: 10.1038/s41467-023-38618-y
pii: 10.1038/s41467-023-38618-y
pmc: PMC10227040
doi:

Substances chimiques

Estradiol 4TI98Z838E
Estrogen Receptor alpha 0
Estrogens 0
Kisspeptins 0
Nr0b1 protein, mouse 0
DAX-1 Orphan Nuclear Receptor 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

3076

Subventions

Organisme : Biotechnology and Biological Sciences Research Council
ID : BB/S017593/1
Pays : United Kingdom
Organisme : Biotechnology and Biological Sciences Research Council
ID : BB/W001497/1
Pays : United Kingdom
Organisme : British Heart Foundation
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UP_1102/3
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UU_00014/1
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 105545/Z/14/Z
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/W018934/1
Pays : United Kingdom

Informations de copyright

© 2023. The Author(s).

Références

Endocrinology. 2015 Mar;156(3):1111-20
pubmed: 25545386
PLoS One. 2019 Aug 13;14(8):e0220311
pubmed: 31408468
Bioinformatics. 2019 Jun 1;35(12):2084-2092
pubmed: 30395178
Mol Genet Metab. 2004 Sep-Oct;83(1-2):60-73
pubmed: 15464421
J Neurosci. 2018 Jul 11;38(28):6310-6322
pubmed: 29899026
Endocrinology. 2018 Nov 1;159(11):3723-3736
pubmed: 30272161
Endocrinology. 2014 Jul;155(7):2555-65
pubmed: 24735328
Genome Res. 2002 Jun;12(6):996-1006
pubmed: 12045153
Proc Natl Acad Sci U S A. 2017 Nov 21;114(47):E10216-E10223
pubmed: 29109258
Endocrinology. 2021 Sep 1;162(9):
pubmed: 33856454
Peptides. 2009 Jan;30(1):83-93
pubmed: 18644414
Biochem Biophys Res Commun. 2020 May 21;526(1):70-77
pubmed: 32192769
J Comp Neurol. 1990 Apr 1;294(1):76-95
pubmed: 2324335
F1000Res. 2019 Jun 28;8:
pubmed: 31297186
Elife. 2019 Apr 04;8:
pubmed: 30946012
Proc Natl Acad Sci U S A. 2007 May 8;104(19):8173-7
pubmed: 17470805
J Comp Neurol. 1997 Dec 8;389(1):81-93
pubmed: 9390761
Front Neuroendocrinol. 2013 Jan;34(1):3-17
pubmed: 22728025
Nat Commun. 2022 Dec 2;13(1):7433
pubmed: 36460649
Brain Res Rev. 2008 Mar;57(2):277-87
pubmed: 17604108
Neuron. 2006 Oct 19;52(2):271-80
pubmed: 17046690
Proc Natl Acad Sci U S A. 2015 Oct 20;112(42):13109-14
pubmed: 26443858
J Neurosci. 2009 Jul 22;29(29):9390-5
pubmed: 19625529
Endocrinology. 2016 Apr;157(4):1555-65
pubmed: 26862996
J Neuroendocrinol. 2012 Jan;24(1):131-43
pubmed: 21592236
Genome Biol. 2014;15(12):550
pubmed: 25516281
J Neurosci. 2015 Apr 29;35(17):6881-92
pubmed: 25926463
J Neuroendocrinol. 2022 May;34(5):e13115
pubmed: 35502534
Endocrinology. 2012 Nov;153(11):5384-93
pubmed: 22989626
Front Neurosci. 2022 Jul 27;16:953252
pubmed: 35968365
Front Neuroendocrinol. 2020 Apr;57:100837
pubmed: 32240664
PLoS Genet. 2007 Jun;3(6):e87
pubmed: 17542648
Nucleic Acids Res. 2019 May 7;47(8):e47
pubmed: 30783653
Endocrinology. 2005 Sep;146(9):3686-92
pubmed: 15919741
J Biol Chem. 2000 Dec 22;275(51):39855-9
pubmed: 11053406
Neuroendocrinology. 2014;99(2):94-107
pubmed: 24686008
Physiology (Bethesda). 2010 Aug;25(4):207-17
pubmed: 20699467
Endocrinology. 2021 Nov 1;162(11):
pubmed: 34383026
J Neurosci. 2018 Jan 31;38(5):1061-1072
pubmed: 29114074
Nature. 2009 Nov 5;462(7269):58-64
pubmed: 19890323
Endocrinology. 2017 Oct 1;158(10):3553-3564
pubmed: 28938398
Proc Natl Acad Sci U S A. 2012 May 15;109(20):E1294-301
pubmed: 22505735
Int J Mol Sci. 2021 Aug 26;22(17):
pubmed: 34502135
Nat Methods. 2015 Apr;12(4):357-60
pubmed: 25751142
Endocrinology. 2012 Nov;153(11):5105-18
pubmed: 22989628
Endocrinology. 2019 Mar 1;160(3):557-567
pubmed: 30649269
Endocrinology. 2013 Dec;154(12):4939-45
pubmed: 24092638
Bioinformatics. 2010 Mar 15;26(6):841-2
pubmed: 20110278
Endocrinology. 2017 Oct 1;158(10):3565-3578
pubmed: 28938464
Proc Natl Acad Sci U S A. 2022 Jul 5;119(27):e2113749119
pubmed: 35763574
J Neuroendocrinol. 2010 Jul;22(7):682-91
pubmed: 20492362

Auteurs

Jose M Ramos-Pittol (JM)

Institute of Biochemistry and Center for Molecular Biosciences Innsbruck, University of Innsbruck, Innsbruck, 6020, Austria.

Isabel Fernandes-Freitas (I)

Section of Investigative Medicine, Imperial College London, London, United Kingdom.

Alexandra Milona (A)

Institute of Clinical Sciences, Imperial College London, London, United Kingdom.

Stephen M Manchishi (SM)

Department of Physiology, Development, and Neuroscience, Cambridge University, Cambridge, United Kingdom.

Kara Rainbow (K)

Medical Research Council Metabolic Diseases Unit, Wellcome-MRC Institute of Metabolic Science-Metabolic Research Laboratories, Cambridge University, Cambridge, United Kingdom.

Brian Y H Lam (BYH)

Medical Research Council Metabolic Diseases Unit, Wellcome-MRC Institute of Metabolic Science-Metabolic Research Laboratories, Cambridge University, Cambridge, United Kingdom.

John A Tadross (JA)

Medical Research Council Metabolic Diseases Unit, Wellcome-MRC Institute of Metabolic Science-Metabolic Research Laboratories, Cambridge University, Cambridge, United Kingdom.
Department of Histopathology and East Midlands & East of England Genomic Laboratory Hub, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.

Anthony Beucher (A)

Section of Genetics and Genomics, Imperial College London, London, United Kingdom.

William H Colledge (WH)

Department of Physiology, Development, and Neuroscience, Cambridge University, Cambridge, United Kingdom.

Inês Cebola (I)

Section of Genetics and Genomics, Imperial College London, London, United Kingdom.

Kevin G Murphy (KG)

Section of Investigative Medicine, Imperial College London, London, United Kingdom.

Irene Miguel-Aliaga (I)

Institute of Clinical Sciences, Imperial College London, London, United Kingdom.
MRC London Institute of Medical Sciences, London, United Kingdom.

Giles S H Yeo (GSH)

Medical Research Council Metabolic Diseases Unit, Wellcome-MRC Institute of Metabolic Science-Metabolic Research Laboratories, Cambridge University, Cambridge, United Kingdom.

Waljit S Dhillo (WS)

Section of Investigative Medicine, Imperial College London, London, United Kingdom. w.dhillo@imperial.ac.uk.

Bryn M Owen (BM)

Section of Investigative Medicine, Imperial College London, London, United Kingdom. bryn.owen05@imperial.ac.uk.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH